One of the most effective strategies in biological systems to demonstrate resistance
to cytotoxic drugs is the efflux of these compounds out of the cell, via membrane
transporter proteins. This phenomenon is called multidrug resistance (MDR) and is
a mediator of drug resistance observed in tumor cells and in microorganisms (in vivo and in vitro) [1]. There are numerous resistance mechanisms and the MDR phenotype alone, can not
completely explain this occurrence. In fact, several other related proteins are also
overexpressed in resistant tumors. Furthermore apoptosis also play a vital role in
resistance [2]. Because apoptosis is a major modality by which different tumor cell
types can be eliminated, the identification of new drugs able to induce the programmed
cell death is an important goal in cancer therapy, and may provide new useful tools
for the treatment of patients with drug resistance malignancies. In this context,
plants could be potential sources for the isolation of new metabolites that could
be used as lead molecules on the treatment of neoplasic diseases.
In our search for biologically active compounds from Euphorbia species, several ergostane and stigmastane steroids were isolated from the methanolic
extract of Euphorbia lagascae, and its structures were deduced by the combination of physical and spectroscopic
data (IR, MS, 1D and 2D NMR). The ability of some of the isolated steroids to modulate
MDR reversion was investigated using mdr-1 (L5178) mouse lymphoma cell line. In addition,
the apoptosis induction on the same cell line was also studied. 12H-benzophenothiazine
was used as a positive control for apoptosis induction and verapamil for resistance
reversal. The tested compounds were weak inducers of apoptosis in the studied mouse
lymphoma cell line, but two of them were found effective on MDR reversion in a concentration
dependent manner.
Acknowledgements: The authors thank Dr. Teresa Vasconcelos (ISA, University of Lisbon, Portugal) for
identification of the plant.
References: 1. Borges-Walmsley, M. et al. (2003), Biochem. J. 376: 313–338. 2. Volm, M. (1998), Anticancer Res. 18: 2905–2917.